Notably, genetic deletion or pharmacological inhibition of hexokinase 2 (HK2) protein that regulates the first rate-limiting step in glycolysis increases Aβ clearance by microglia via upregulating lipid metabolism in AD mice [16]. Here, HK2 is linked to Alzheimer disease.